• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶血磷脂受体

Lysophospholipid receptors.

作者信息

Fukushima N, Ishii I, Contos J J, Weiner J A, Chun J

机构信息

Neuroscience Program, Department of Pharmacology, University of California, San Diego, La Jolla, California 92093-0636, USA.

出版信息

Annu Rev Pharmacol Toxicol. 2001;41:507-34. doi: 10.1146/annurev.pharmtox.41.1.507.

DOI:10.1146/annurev.pharmtox.41.1.507
PMID:11264467
Abstract

Lysophospholipids (LPs), including lysophosphatidic acid and sphingosine 1-phosphate, produce many cellular effects. However, the prolonged absence of any cloned and identified LP receptor has left open the question of how these lipids actually bring about these effects. The cloning and functional identification of the first LP receptor, lp(A1)/vzg-1, has led rapidly to the identification and classification of multiple orphan receptors/expression sequence tags known by many names (e.g. edg, mrec1.3, gpcr26, H218, AGR16, nrg-1) as members of a common cognate G protein-coupled receptor family. We review features of the LP receptor family, including molecular characteristics, genomics, signaling properties, and gene expression. A major question for which only partial answers are available concerns the biological significance of receptor-mediated LP signaling. Recent studies that demonstrate the role of receptor-mediated LP signaling in the nervous system, cardiovascular system, and other organ systems indicate the importance of this signaling in development, function, and pathophysiology and portend an exciting time ahead for this growing field.

摘要

溶血磷脂(LPs),包括溶血磷脂酸和1 -磷酸鞘氨醇,会产生多种细胞效应。然而,长期以来一直没有克隆和鉴定出任何溶血磷脂受体,这使得这些脂质究竟如何产生这些效应的问题悬而未决。首个溶血磷脂受体lp(A1)/vzg-1的克隆和功能鉴定,迅速导致多个以许多名称为人所知的孤儿受体/表达序列标签(如edg、mrec1.3、gpcr26、H218、AGR16、nrg-1)被鉴定并归类为一个共同的同源G蛋白偶联受体家族的成员。我们综述了溶血磷脂受体家族的特征,包括分子特性、基因组学、信号转导特性和基因表达。对于受体介导的溶血磷脂信号传导的生物学意义,目前只有部分答案的一个主要问题。最近的研究表明受体介导的溶血磷脂信号传导在神经系统、心血管系统和其他器官系统中的作用,表明这种信号传导在发育、功能和病理生理学中的重要性,并预示着这个不断发展的领域将迎来令人兴奋的未来。

相似文献

1
Lysophospholipid receptors.溶血磷脂受体
Annu Rev Pharmacol Toxicol. 2001;41:507-34. doi: 10.1146/annurev.pharmtox.41.1.507.
2
A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs).一个不断扩大的溶血磷脂酸(LPA)和其他溶血磷脂(LP)受体基因家族。
Cell Biochem Biophys. 1999;30(2):213-42. doi: 10.1007/BF02738068.
3
Neurobiology of receptor-mediated lysophospholipid signaling. From the first lysophospholipid receptor to roles in nervous system function and development.受体介导的溶血磷脂信号传导的神经生物学。从首个溶血磷脂受体到其在神经系统功能和发育中的作用
Ann N Y Acad Sci. 2000 Apr;905:110-7. doi: 10.1111/j.1749-6632.2000.tb06543.x.
4
Lysophospholipid receptors in the nervous system.
Neurochem Res. 2002 Aug;27(7-8):619-27. doi: 10.1023/a:1020219915922.
5
Lysophospholipids--receptor revelations.溶血磷脂——受体的新发现
Science. 2001 Nov 30;294(5548):1875-8. doi: 10.1126/science.1065323.
6
Biological effects of lysophospholipids.溶血磷脂的生物学效应。
Rev Physiol Biochem Pharmacol. 2008;160:25-46. doi: 10.1007/112_0507.
7
Lysophospholipid receptors: signaling and biology.溶血磷脂受体:信号传导与生物学
Annu Rev Biochem. 2004;73:321-54. doi: 10.1146/annurev.biochem.73.011303.073731.
8
Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system.利用逆转录病毒表达系统对神经元细胞系中溶血磷脂酸受体LP(A1)/VZG-1/EDG-2、LP(A2)/EDG-4和LP(A3)/EDG-7进行功能比较。
Mol Pharmacol. 2000 Nov;58(5):895-902. doi: 10.1124/mol.58.5.895.
9
Lysophospholipid receptors: implications for neural signaling.溶血磷脂受体:对神经信号传导的影响。
Crit Rev Neurobiol. 1999;13(2):151-68. doi: 10.1615/critrevneurobiol.v13.i2.20.
10
The first cloned and identified lysophospholipid (LP) receptor gene, vzg-1: implications for related receptors and the nervous system.
Adv Exp Med Biol. 1999;469:357-62. doi: 10.1007/978-1-4615-4793-8_52.

引用本文的文献

1
Characterization of Lysophospholipase D Activity in Mammalian Cell Membranes.哺乳动物细胞膜中溶血磷脂酶 D 活性的表征。
Cells. 2024 Mar 16;13(6):520. doi: 10.3390/cells13060520.
2
Lysophosphatidic acid exerts protective effects on HEI-OC1 cells against cytotoxicity of cisplatin by decreasing apoptosis, excessive autophagy, and accumulation of ROS.溶血磷脂酸通过减少细胞凋亡、过度自噬和活性氧的积累,对HEI-OC1细胞发挥抗顺铂细胞毒性的保护作用。
Cell Death Discov. 2023 Nov 15;9(1):415. doi: 10.1038/s41420-023-01706-5.
3
LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration.
LPA1 介导的 CXCR4 抑制作用可减弱 CXCL12 诱导的信号转导和细胞迁移。
Cell Commun Signal. 2023 Sep 25;21(1):257. doi: 10.1186/s12964-023-01261-7.
4
Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases.溶血磷脂酸在巨噬细胞和炎症性疾病中的新作用。
Int J Mol Sci. 2023 Aug 7;24(15):12524. doi: 10.3390/ijms241512524.
5
Lysophosphatidic acid induces proliferation and osteogenic differentiation of human dental pulp stem cell through lysophosphatidic acid receptor 3/extracellular signal-regulated kinase signaling axis.溶血磷脂酸通过溶血磷脂酸受体3/细胞外信号调节激酶信号轴诱导人牙髓干细胞增殖和成骨分化。
J Dent Sci. 2023 Jul;18(3):1219-1226. doi: 10.1016/j.jds.2023.01.029. Epub 2023 Feb 9.
6
Lipid Metabolic Alterations in KRAS Mutant Tumors: Unmasking New Vulnerabilities for Cancer Therapy.KRAS 突变肿瘤中的脂质代谢改变:揭示癌症治疗的新弱点。
Int J Mol Sci. 2023 Jan 16;24(2):1793. doi: 10.3390/ijms24021793.
7
The LPA-CDK5-tau pathway mediates neuronal injury in an in vitro model of ischemia-reperfusion insult.LPA-CDK5-tau 通路介导体外缺血再灌注损伤模型中的神经元损伤。
BMC Neurol. 2022 May 2;22(1):166. doi: 10.1186/s12883-022-02694-2.
8
Generation of an Lpar1-EGFP Fusion Knock-in Transgenic Mouse Line.生成 Lpar1-EGFP 融合基因敲入转基因小鼠品系。
Cell Biochem Biophys. 2021 Sep;79(3):619-627. doi: 10.1007/s12013-021-01033-5. Epub 2021 Oct 15.
9
Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies.溶血磷脂酸及其受体在健康和疾病中的作用:新的治疗策略。
Signal Transduct Target Ther. 2021 Feb 1;6(1):45. doi: 10.1038/s41392-020-00367-5.
10
Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects.鞘氨醇 1-磷酸受体调节剂治疗多发性硬化症:下游受体信号转导和临床特征的差异效应。
Drugs. 2021 Feb;81(2):207-231. doi: 10.1007/s40265-020-01431-8.